ProMIS is a Canada-based biotechnology company that researches and develops novel antibody therapeutics for the treatment of neurodegenerative diseases.
Business Model:
Revenue: $17.2k
Employees: 2-10
Address: 1920 Yonge Street
City: Toronto
State: ontario
Zip: M4S 3E2
Country: CA
ProMIS is a Canada-based biotechnology company that researches and develops novel antibody therapeutics for the treatment of neurodegenerative diseases.
Contact Phone:
+14168476898
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/7/2005
Ticker Symbol:
PMN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2018 | Post-IPO Equity | $5.6M | 4/2013 | Post-IPO Equity | $128.2k | 1/2014 | Post-IPO Equity | $256.1k | 12/2019 | Post-IPO Equity | - | 7/2015 | Post-IPO Equity | $434.2k | 6/2016 | Post-IPO Equity | $460k | 3/2014 | Post-IPO Equity | $379.2k | 3/2013 | Post-IPO Equity | $25.2k | 7/2017 | Grant | $262.5k | 12/2019 | Private Placement | $570.1k | 2/2014 | Post-IPO Equity | $251.8k | 8/2015 | Post-IPO Equity | $150.3k | 10/2022 | Private Placement | $7.5M | 8/2021 | Post-IPO Equity | $20.1M |
The Kraft Group |
3/2021 | Post-IPO Equity | $7M | 11/2020 | Private Placement | $1.7M | 5/2012 | Post-IPO Equity | $20k | 3/2011 | Post-IPO Equity | $350k | 1/2012 | Post-IPO Equity | $100.5k | 5/2013 | Post-IPO Equity | $114k | 12/2019 | Post-IPO Equity | - | 5/2018 | Post-IPO Equity | $5.6M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|